Bio*One Capital logo

Bio*One Capital

Asia, Central Region, Singapore, Singapore

Description

Bio*One Capital is a venture capital firm that invest in the healthcare information technology, medical, and therapeutics industries.

Investor Profile

Bio*One Capital has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Series D rounds (top funding stages).
  • Majority of deals are located in Germany, United States.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Series Unknown (50%)
  • Series D (50%)

Country Focus

  • Germany (50%)
  • United States (50%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Bio*One Capital frequently co-invest with?

LSP BioVentures
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Edmond de Rothschild Private Equity
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Pac-Link
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 1
Shepherd Ventures
North America, California, United States, San Diego
Co-Investments: 1
Essex Woodlands Healthcare Partners
North America, California, United States, Palo Alto
Co-Investments: 1
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Technology Partners
North America, California, United States, Palo Alto
Co-Investments: 1
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 1
EDBI
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Palo Alto Investors
North America, California, United States, Palo Alto
Co-Investments: 1

What are some of recent deals done by Bio*One Capital?

Revance Therapeutics

Newark, California, United States

Revance is a biotechnology company focusing on aesthetic and therapeutic offerings that enhance patient outcomes and physician experiences.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series DDec 28, 2009
Amount Raised: $25,620,000
U3 Pharma

Planegg, Bayern, Germany

U3 Pharma is a pharmaceutical company that focuses in targeted cancer drug development.

BiotechnologyHealth Care
Series UnknownMay 22, 2006
Amount Raised: $34,000,000